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Self-efficacy for health-related behaviour change in
patients with TIA or minor ischemic stroke
Dorien Brouwer-Goossensena, Lenneke van Genugtena, Hester F. Lingsmaa,
Diederik W. J. Dippela, Peter J. Koudstaala and Heleen M. den Hertogb
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ABSTRACT
Objective: To assess levels of self-efficacy for health-related
behaviour change and its correlates in patients with TIA or ische-
mic stroke.
Methods: In this prospective cohort study, 92 patients with TIA
or ischemic stroke completed questionnaires on self-efficacy for
health-related behaviour change and fear, social support and
depressive symptoms. Relations between fear, social support,
depressive symptoms, cognitive impairment, vascular risk fac-
tors and history and demographic characteristics and low-self-
efficacy were studied with univariable and multivariable logis-
tic regression.
Results: Median total self-efficacy score at baseline was 4 (IQR
4–5). Older age (OR 1.05, 95% CI 1.01–1.09), depressive symptoms
(OR 1.09, 95% CI 1.03–1.16), presence of vascular history (OR 2.42,
95% CI 0.97–6.03), higher BMI (OR 1.15, 95% CI 1.01–1.30), fear (OR
1.06, 95% CI 1.01–1.12) and low physical activity (OR 1.49, 95% CI
1.01–2.21) were significantly associated with low self-efficacy.
Conclusion: Patients with recent TIA or ischemic stroke report
high self-efficacy scores for health-related behaviour change. Age,
vascular history, more depressive symptoms, higher BMI, less phys-
ical activity and fear were correlates of low self-efficacy levels.
Practice implications: These correlates should be taken into
account in the development of interventions to support patients
in health behaviour change after TIA or ischemic stroke.
KEYWORDS
Stroke; TIA; health-related
behaviour; self-efficacy
Background
The modification of health behaviour is an important part of cardiovascular disease
risk management. Secondary prevention programs focusing on lifestyle modification,
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such as cardiac rehabilitation have positive effects on health outcomes. However, for
patients with stroke or TIA (defined by Easton et al., 2009 as brief episodes of neuro-
logical dysfunction resulting from focal cerebral ischemia not associated with perman-
ent cerebral infarction), insufficient data are available on the effect of lifestyle
modification and current guidelines were drawn on data extrapolated from epidemio-
logical studies or cardiac rehabilitation (Ellis, Rodger, McAlpine, & Langhorne, 2005;
European Stroke Initiative Executive Committee et al., 2003; Lawrence, Kerr, Watson,
Paton, & Ellis, 2010; Lennon, Galvin, Smith, Doody, & Blake, 2013; Maasland, Koudstaal,
Habbema, & Dippel, 2007; Rodgers et al., 1999; Sit, Yip, Ko, Gun, & Lee, 2007).
Moreover, studies have shown that the majority of people with cardiovascular disease
fail to sustain lifestyle modification in the long-term.
The social cognitive theory describes how cognitive, behavioural, personal and
environmental factors determine behaviour and motivation (Bandura, 1986; Wood &
Bandura, 1989). One of the factors that play a central role in this process is perceived
self-efficacy. Self-efficacy (a person’s confidence to carry out behaviour necessary to
reach a desired goal) is an important precondition for successful self-management
(Bandura, 1998; Sol, van der Bijl, Banga, & Visseren, 2005) In our previous study
(Brouwer-Goossensen et al., 2016), we found that self-efficacy was the strongest deter-
minant of intention to stop smoking, increase physical activity and improve healthy
diet. Self-efficacy was also a powerful predictor of intention to change in other cardio-
vascular studies (Garcia & Mann, 2003; Sniehotta, Scholz, & Schwarzer, 2005; Sol et al.,
2005; Sol, van der Graaf, van Petersen, & Visseren, 2006; Vries, Dijkstra, & Kuhlman,
1988). It has been found to have a direct effect on health-related behaviour and is the
strongest predictor of health-related behaviour change (Schwarzer & Fuchs, 1995; Vries
et al., 1988). Hence, increasing self-efficacy could be a way to support health-related
behaviour change in patients with TIA or ischemic stroke. Modulation of self-efficacy
has proven to be effective in changing health related behaviour in patients with over-
weight and in healthy individuals of different ages (Bandura, 1998; Barlow, Wright,
Sheasby, Turner, & Hainsworth, 2002; Brouwer-Goossensen et al., 2016; Garcia & Mann,
2003; Schwarzer & Fuchs, 1995; Sniehotta et al., 2005; Sol et al., 2006; Vries et al.,
1988) and is for example possible by means of self-management interventions. There
is growing evidence that these self-management approaches are effective in increasing
self-efficacy (Barlow et al., 2002). The literature on ‘self-management’ after stroke is
limited. Nevertheless, a systematic meta-review based on 13 systematic reviews which
studies core elements of self-management support including problem solving, decision
making and goal setting found high quality evidence that therapy rehabilitation incor-
porating these elements delivered soon after a stroke improves ADL and extended
ADL and reduces the risk of dependence and mortality. As far as we know, there is no
clear evidence how to improve self-management for behaviour change in stroke
patients. At present also, little is known about correlates of self-efficacy for health
related behaviour change in patients with stroke or TIA and it may be different from
other vascular conditions, as stroke patients are generally older and often have cogni-
tive and/or functional impairment. Studies on self-efficacy in patients with TIA or
ischemic stroke have shown that patients with high self-efficacy report significantly
fewer depressive symptoms, were more likely to meet exercise recommendations,
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were younger and not overweight (Jones & Riazi, 2011; Korpershoek, van der Bijl, &
Hafsteinsdottir, 2011; Robinson-Smith, Johnston, & Allen, 2000; Shaughnessy, Resnick,
& Macko, 2006). However, these studies did not focus on health-related behaviour
change. In patients with cardiovascular diseases, diabetes and smoking were related
to low levels of self-efficacy (Sol et al., 2006). It is unknown yet if diabetes and smok-
ing are associated with self-efficacy in patients with TIA or ischemic stroke as well.
Self-efficacy can be developed by mastery experiences (successes build a robust
belief in one’s personal efficacy), vicarious models (role models), social persuasion
(social support) and psychological and emotional arousal(Bandura, 1998). Social sup-
port is therefore an important requirement for health-related behaviour change by
adequate self-management (Bandura, 1998; Marks, Allegrante, & Lorig, 2005). Social
support is known to influence physical activity after stroke, but it is unclear whether it
has a role in improving self-efficacy (Adeniyi, Idowu, Ogwumike, & Adeniyi, 2012;
Morris, Oliver, Kroll, & Macgillivray, 2012; Prout, Mansfield, McIlroy, & Brooks, 2017).On
the other hand, fear and depression can also affect self-efficacy and are often present
after stroke and (Dawood et al., 2008; Gerber et al., 2011). An earlier study showed
that fear was independently associated with intention to change health-related behav-
iour (Sniehotta et al., 2005) and depression is known to influence health behaviour
change in myocardial infarction patients.
At present, it is unclear how to support patients in changing health-related behav-
iour after TIA or ischemic stroke. Insight in the correlates of self-efficacy can be helpful
by developing interventions to increase self-efficacy and thereby support patients with
TIA or minor ischemic stroke with health-related behaviour change and to select
patient groups on which the interventions should be focused. In this study, we aimed
to describe levels of self-efficacy of health-related behaviour change and identify cor-
relates of self-efficacy in patients with ischemic stroke or TIA.
Methods
All patients included in the present study participated in the DECIDE study. Detailed
methods of the DECIDE study have been described earlier (Brouwer-Goossensen et al.,
2016). In short, DECIDE was a prospective study on determinants of intention to
change health-related behaviour and actual change in patients with TIA or ischemic
stroke. Patients of 18 years or older with a clinical diagnosis of TIA, including amaur-
osis fugax, or minor ischemic stroke with a modified Rankin Scale score (mRS) 2 or
less were included during admission on the stroke unit or outpatient clinic.
Baseline data
We recorded data on clinical features of TIA or ischemic stroke, quantification of stroke
severity according to the National Institutes of Health stroke scale (Schlegel et al.,
2003; NIHSS, a 15-item scale with scores that range from 0 to 42 and higher values
indicating greater severity), demographic data, vascular risk factors and history, weight,
length, BMI and use of medication. Patient were assessed at baseline (directly after
inclusion) and 3 months later in the DECIDE study. However, as self-efficacy did not
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change in this 3-months follow up, we only used baseline data in this study.
The assessment included self-reported questionnaires on self-efficacy, fear, social sup-
port, depressive symptoms, health-related behaviour and social support. Furthermore,
all patients underwent a cognitive assessment. The following questionnaires
were completed:
 Self-efficacy was measured with the self-efficacy scale, a 7-item scale with scores
that range from 1 to 5 (Bijl, Poelgeest-Eeltink, & Shortridge-Baggett, 1999). Higher
values indicate more confidence to carry out the behaviour necessary to reach the
desired goal. Cronbach’s a of the self-efficacy questionnaire was 0.75. This scale has
been used successfully before in in vascular patients (Sol et al., 2005, 2006; Sol, van
der Graaf, van der Bijl, Goessens, & Visseren, 2011; Sol, van der Graaf, van der Bijl,
Goessens, & Visseren, 2008).
 Fear was assessed with eight questions. Patients were asked on a scale of 1 to 5
how nervous they are when thinking of getting another stroke, how upset they
get, depressed or jittery, if their heart beats faster, an if they feel uneasy or anxiou
(Champion et al., 2004).
 Social support was evaluated with the aspects of Active engagement, Protective
buffering and Overprotection (ABO) social support questionnaire for Dutch coron-
ary heart disease patients (Buunk, Berkhuysen, Sanderman, Nieuwland, & Ranchor,
1996). This questionnaire includes five statements about active involvement, eight
statements concerning protective buffering and six about overprotection, of which
respondents can respond on a 5-point scale, ranging from (0) ‘very often’ to
(4) ‘never’.
 Depressive symptoms were assessed with the CES-D (centre for Epidemiologic
Studies Depression Scale) for both depression and anxiety (Beekman et al., 1997;
Beekman, van, Deeg, Wouters, & van, 1994). Higher scores indicate more depres-
sive symptoms.
 Physical activity was assessed with the International Physical Activity Questionnaire
short (IPAQ-S) questionnaire. Patients were asked to report activities performed for
at least 10minutes during the last 7 days, and time spent in physical activity per-
formed across leisure time, work, domestic activities and transport at each of three
intensities: walking, moderate and vigorous (Plotnikoff, 1998). We used reported
minutes of moderate and vigorous physical activity to calculate a total physical
activity score of minutes a day. As included patients had a mRS score of 2 or less
they were able to walk without assistance and look after their own affairs with-
out assistance.
 Dietary behaviour was assessed with the short Food Frequency Questionnaire (FFF).
This 14-item scale assesses the intake of saturated fatty acids, unsaturated fatty
acids and fruits and vegetables over the week before the visit. An overall cardiovas-
cular dietary score was calculated, ranging from –17 to þ19, the higher the score,
the more favourable the dietary pattern (Mahe et al., 2010).
 Smoking status was assessed with questions on current smoking status, how many
years they have smoked and how much cigarettes a patient smokes a day.
Smoking was defined as current smoking.
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 Cognitive impairment was assessed with Montreal Cognitive assessment (MoCA), a
rapid screening instrument for cognitive impairment, in particular for stroke
patients (Nasreddine et al., 2005)
Statistical analysis
Self-efficacy was dichotomised into high self-efficacy and low self-efficacy based on
the median self-efficacy score. Differences in demographic data, event characteristics,
vascular history and risk factors, health-related behaviour, cognition, depressive symp-
toms, fear and social support, between low and high self-efficacy were studied with t-
tests. Non-normal distributed data were analysed with Mann-Whitney U tests. We
studied the relation between correlates of behaviour change and low self-efficacy with
univariable logistic regression analysis. Physical activity was unequally distributed and
was log transformed, before the univariable linear regression analysis. Correlates with
a p value of < .06 were further analysed with multivariable logistic regression. The
relation between correlates and continuous self-efficacy score was also analysed in
univariable and multivariable linear regression. Statistical analysis was performed with
STATA 12.1 statistical package (Statacorp, College Station, Texas).
Table 2. Self-efficacy for behaviour change.
Baseline
Total, median (IQ) 4.3 (3.9–4.7)
Medication, median (IQ) 5 (5–5)
Smoking, median (IQ) 4 (3–5)
Diet at home, median (IQ) 5 (4–5)
Diet when not at home, median (IQ) 4 (4–5)
Physical activity, median (IQ) 5 (4–5)
Weight maintenance, median (IQ) 4 (4–5)
Weight reducing, median (IQ) 4 (3–5)
Table 3. Relations between dichotomised self-efficacy and correlates of behaviour change univari-
able and multivariable logistic regression analysis.
OR (95% CI) p aOR (95% CI) p
Age 0.95 (0.92–0.99) .02 0.95 (0.90–1.00) .07
Vascular history 0.41 (0.17–1.02) .06 0.61 (0.19–2.05) .43
CES-D 0.92 (0.86–0.97) .01 0.91 (0.84–0.99) .03
BMI 0.87 (0.77–0.99) .03 0.79 (0.65–0.96) .02
Fear 0.94 (0.89–0.99) .02 0.96 (0.89–1.03) .26
Physical activity 1.49 (1.01–2.21) .05 1.58 (0.95–2.64) .08
Table 4. Relations between correlates and self-efficacy, univariable and multivariable regres-
sion analysis.
Beta (CI) p aBeta (95% CI) p
Age –0.00 (–0.02 to 0.00) .14 –0.00 (–0.02 to 0.00) .07
Vascular history –0.21 (–0.48 to 0.07) .14 0.05 (–0.21 to 0.32) .69
CES-D –0.04 (–0.05 to –0.02) .00 –0.02 (–0.04 to 0.01) .01
BMI –0.05 (–0.09 to –0.01) .01 –0.05 (–0.10 to –0.02) .01
Fear –0.03 (–0.04 to 0.01) .00 –0.02 (–0.03 to 0.00) .06
Physical activity 0.03 (–0.08 to 0.14) .56 0.04 (–0.07 to 0.15) .50
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Results
Ninety-two patients were included between February and October 2012. Mean age
was 64 years (SD 12), 55 (60%) of the patients were male and 49 (53%) had a TIA
(Table 1). Patients had a moderately healthy lifestyle; median physical exercise was
137minutes a day (interquartile range 62–219), mean BMI was 27 (SD 3.6) and median
overall diet score 0 (interquartile range –2 to 2), Only 5 (6%) patients used more alco-
hol than advised and 32 (35%) of the patients were smokers.
Median total self-efficacy score at baseline was 4.3 (IQR 3.9–4.7, Table 2) and self-
efficacy did not change in 3 months follow-up (data not shown). Thirty patients (33%)
had low self-efficacy scores for health-related behaviour change.
Older age (OR 1.05, 95% CI 1.01–1.09), depressive symptoms (OR 1.09, 95% CI
1.03–1.16), vascular history (OR 2.42, 95% CI 0.97–6.03), higher BMI (OR 1.15, 95% CI
1.01–1.30), higher fear (OR 1.06, 95% CI 1.01–1.12) and low physical activity (OR 1.49,
95% CI 1.01–2.21) were significantly associated with low self-efficacy for improving
health-related behaviour change, with BMI and depressive symptoms as the strongest
correlates (Tables 3 and 4).
Discussion and conclusion
In this study, we found that patients with recent TIA or ischemic stroke report high
self-efficacy scores for health-related behaviour change. Older patients, and those with
vascular history, more depressive symptoms scores, higher BMI, less physical activity
and increased fear had lower levels of self-efficacy for health-related behaviour
change. Of these prognostic factors, depressive symptoms and BMI were the strongest
(Table 4).
This is one of the first studies that assessed correlates of self-efficacy for health-
related behaviour change in patients with TIA a minor ischemic stroke. Self-efficacy for
behaviour change appeared to be high in our patients as earlier studies using the
same self-efficacy scale (Sol et al., 2011, 2008, 2006) found comparable total self-effi-
cacy scores, but disaggregated self-efficacy scores were lower. In line with our results,
two other studies showed that patients with high self-efficacy had significantly less
depressive symptoms (Jones & Riazi, 2011; Korpershoek et al., 2011; Robinson-Smith
et al., 2000), were more likely to meet exercise recommendations (Korpershoek et al.,
2011; Shaughnessy et al., 2006; Sol et al., 2011) were younger, and not overweight
(Shaughnessy et al., 2006; Sol et al., 2006). In studies with patients with vascular dis-
ease (coronary heart disease, cerebrovascular disease or peripheral artery disease) hav-
ing diabetes and smoking were significantly associated with lower levels of self-
efficacy in contrast to our results (Sol et al., 2006, 2011). We found only one study in
which vascular history as determinant of self-efficacy for health related behaviour
change was studied in patients with vascular diseases. In this cross-sectional study
with 236 patients, no association between vascular history and self-efficacy was found
(Sol et al., 2006). As far as we know, fear has not been studied in relation to self-effi-
cacy for health-related behaviour change in patients with TIA or ischemic stroke or
other vascular diseases. Earlier studies in general populations showed a significant
interaction between threat (fear) and self-efficacy, such that threat only had an
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motivating effect when high efficacy is present (Peters, Ruiter, & Kok, 2013). The asso-
ciation between low self-efficacy scores for behaviour change and depressive symp-
toms has also been earlier described in general populations (Bandura, 1997; Kavanagh,
1992). Social support is considered to be an important requirement of health-related
behaviour change by adequate self-management (Bandura, 1998; Marks et al., 2005),
but in our study we found no relation between social support and self-efficacy.
A strength of our study is that we collected detailed information on potential
correlates of self-efficacy. This included both patient characteristics and correlates
of health-related behaviour change. Our study also has some limitations. First, we
studied patients for a relatively short period of time after their TIA or minor ische-
mic stroke. In this period, patients possibly did not adequately appraise their situ-
ation. On one hand this effect may not be very strong, because self-efficacy did
not change over a period of 3 months. On the other hand, patients often rehabili-
tate in the first months after discharge. The positive feed-back and support in this
period can provide a boosting effect on self-efficacy. Second, self-efficacy for
health-related behaviour change appeared to be high in patients with TIA or minor
ischemic stroke. The self-efficacy scale used in our study has only been applied in
three earlier studies by Sol et al. (2006, 2008, 2011) in patients with symptomatic
vascular diseases (cerebrovascular disease, abdominal aortic aneurysm or peripheral
arterial disease). In these studies, total self-efficacy was comparable to our findings,
but disaggregated self-efficacy scores were lower. Furthermore, social desirability
bias during questionnaire completion may also have played a role as self-efficacy is
high in these patients where our earlier study showed that most patients do not
actually change their behaviour, due to the intention-behaviour gap (Brouwer-
Goossensen et al., 2016; Sheeran, 2002). Sol et al. (2008) described how subsequent
underestimation of the difficulty of self-management of vascular risk can be
another explanation for high self-efficacy scores. The questions seem simple, caus-
ing high scores while the tasks are very difficult. We analysed several correlates in
this study which can lead to type 1 errors. Also it cannot be completely excluded
that our results were affected by possible confounders. Although for instance the
low mRs and NIHSS suggests that these patients are mildly or not impaired, factors
such as fatigue, visual loss or inactivity can affect the relation between physical
activity and self-efficacy as well. There was also a small (but not significant differ-
ence) in cognition between patients with high-self efficacy and low self-efficacy.
However, in linear regression analysis (adjusted for age, data not shown) we found
no significant relation between self-efficacy and cognition.
The results of our study suggest that vulnerable patients have lower self-efficacy
scores. Older patients often experience more physical discomfort that may result in
feeling less confident. Also vascular history or depressive symptoms can affect the
patients’ perception of their physical and mental capability, resulting in low self-effi-
cacy. Patients with higher fear had lower self-efficacy levels. In contrast to our study, a
meta-analysis of fear studied in different populations and different behaviours has
shown a significant interaction between threat (fear) and efficacy, in these studies
threat only had a motivating effect when high efficacy is present (Peters et al., 2013).
Possibly, fear results in counterproductive behaviour in our patients, and leads to
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avoidance- or denial-based forms of coping, explaining the association with low self-
efficacy. We expected social support to play a role in building self-efficacy, as it plays
a role in self-management. However, we found no relation between social support
and self-efficacy. Possibly social support influences self-management in a different
kind than by improving self-efficacy. For example, the effect of old age, vascular his-
tory and fear on self-efficacy can be so intense that the social support patients experi-
ence cannot compensate the effects of these correlates.
At present, the mechanism of building self-efficacy is not completely clear. On the
one hand, factors as vascular history, age, depressive symptoms and fear can influence
self-efficacy. On the other hand, self-efficacy may influence these factors as well. For
example, lack of confidence and low self-efficacy can possibly lead to less control of
health-related related behaviour resulting in overweight, less physical activity and con-
tinuing smoking. Vice versa, being overweight, less physical active or not being able
to quit smoking can also affect the sense of control over one’s life with consequently
low self-efficacy.
Self-efficacy is an important precondition for behaviour change. Therefore, increas-
ing self-efficacy could be a way to support health behaviour change in patients with
TIA or ischemic stroke. As far as we know, a few studies focused on improving self-effi-
cacy or self-management in patients with TIA or ischemic stroke (Huijbregts, Myers,
Streiner, & Teasell, 2008; Johnston et al., 2007; Jones, Mandy, & Partridge, 2009;
Kendall et al., 2007), but we identified only one study which focused on self-efficacy
for health-related behaviour change (Sol et al., 2008). In this study, self-efficacy for
healthy food and physical exercise improved by the nursing intervention. As self-effi-
cacy can be developed by mastery experiences (successes build a robust belief in
one’s personal efficacy), vicarious models (role models), social persuasion (social sup-
port) and psychological and emotional arousal (Bandura, 1998), these self-manage-
ment programs should be built on these factors. Motivational interviewing can also be
used to help patients exercise more, lose weight, reduce problematic substance use
and stimulate self-efficacy in their ability to make health-related behaviour
changes(Lundahl et al., 2013).
Our study provides insight in self-efficacy and factors associated with self-efficacy
in patients with a recent TIA or minor ischemic stroke. Future studies should focus
on interventions that can influence self-efficacy and should focus on the effects of
supporting these patients in health-related behaviour change by increasing
self-efficacy.
In the development of interventions to support patients in health behaviour
change after TIA or ischemic stroke, the correlates of self-efficacy can be taken into
account. Patients of older age, vascular history, more depressive symptoms scores,
low physical activity, higher BMI and increased fear deserve additional attention in
these programs, for example by extra visits or more intense support. Self-efficacy
can be easily measured and could provide an early and direct indication of
patients’ capability to change and the intensity of support needed. Therefore, a
tailored self-management program using motivational interviewing could be a very
promising method to support patients in health-related behaviour change after TIA
or ischemic stroke.
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